by Sowmya Viswanathan | Mar 12, 2018
Dr. Sheng Lin-Gibson is the Chief of Biosystems and Biomaterials Division at the U.S. National Institute of Standards and Technology (NIST) and directs its Regenerative Medicine Programs. She serves as the Convenor of ISO/TC 276: Biotechnology Working Group...
by Stacey Johnson | Mar 6, 2018
Trustees at the Halton Catholic District School Board adopted a motion last week to ban board donations to non-profits or charities that publicly support “either directly or indirectly, abortion, contraception, sterilization, euthanasia, or embryonic stem cell...
by Patrick Bedford | Feb 26, 2018
Regenerative medicine researchers are making enormous strides to discover more about diseases and disease treatments. From heart regeneration to cancer immunotherapies to gene therapies, they are doing some of the most exciting research today, and some of them are...
by Stacey Johnson | Feb 2, 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event...
by Sowmya Viswanathan | Nov 30, 2017
The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...
Comments